Cargando…
Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
Introduction: Interleukin 6 receptor inhibition by tocilizumab (TCZ) has been effectively used worldwide for the treatment of multisystem inflammatory syndrome (MIS) associated with COVID-19. In this single centre study, we compared the outcome of COVID-19 pneumonia in TCZ-treated vs. untreated (con...
Autores principales: | Kardos, Zsófia, Szabó, Miklós, Baráth, Zsuzsanna, Miksi, Ágnes, Oláh, Csaba, Kozma, Ádám, Gergely, József A., Csánky, Eszter, Szekanecz, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953028/ https://www.ncbi.nlm.nih.gov/pubmed/36830885 http://dx.doi.org/10.3390/biomedicines11020349 |
Ejemplares similares
-
Severity and prognostic factors of SARS-CoV-2-induced pneumonia: The value of clinical and laboratory biomarkers and the A-DROP score
por: Szabó, Miklós, et al.
Publicado: (2022) -
The importance of chest CT severity score and lung CT patterns in risk assessment in COVID-19-associated pneumonia: a comparative study
por: Szabó, Miklós, et al.
Publicado: (2023) -
Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product
por: Szabo, Miklos, et al.
Publicado: (2022) -
Cognitive dysfunction in autoimmune rheumatic diseases
por: Oláh, Csaba, et al.
Publicado: (2020) -
The Alterations of Serum N-glycome in Response to SARS-CoV-2 Vaccination
por: Dojcsák, Dalma, et al.
Publicado: (2023)